Research output per year
Research output per year
Personal profile
Personal profile
Treatment Philosophy
Cancer treatment and bone marrow transplant represent a journey for my patients and their families, and it’s my sincere privilege to be a part of this experience. I consider us all to be critical members of a cohesive team in making the right decisions to meet my patients’ treatment goals while maintaining quality of life.
Research interests
- Allogeneic stem cell transplantation using alternative donors
- Treatment and stem cell transplantation for multiple myeloma, lymphoma and leukemias, myelodysplasia, myeloproliferative disease and myelofibrosis
URL
External positions
NCCN, Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrom's Macroglobulinemia Panel
Fingerprint
Dive into the research topics where Henry C. Fung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments
Furqan, F., Ahn, K. W., Kaur, M., Patel, J., Ansell, S., Awan, F. T., Baird, J., Bezerra, E., Farooq, U., Fung, H., Khurana, A., Lekakis, L., Lutfi, F., McCarty, J., Mukherjee, A., Nath, R., Romancik, J., Schuster, S. J., Smith, M. & Winter, A. & 5 others, , Apr 15 2025, (E-pub ahead of print) In: American Journal of Hematology.Research output: Contribution to journal › Article › peer-review
-
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Jacobson, C. A., Chavez, J. C., Sehgal, A. R., William, B. M., Munoz, J., Salles, G., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Yakoub-Agha, I., Oluwole, O. O., Fung, H. C. H., Rosenblatt, J., Rossi, J. M., Goyal, L., Plaks, V. & Yang, Y. & 3 others, , Jan 2022, In: The Lancet Oncology. 23, 1, p. 91-103 13 p.Research output: Contribution to journal › Article › peer-review
438 Scopus citations -
KTE-X19 CAR T-Cell therapy in relapsed or refractory mantle-cell lymphoma
Wang, M., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T., Timmerman, J. M., Holmes, H., Jaglowski, S., Flinn, I. W., McSweeney, P. A., Miklos, D. B., Pagel, J. M., Kersten, M. J., Milpied, N., Fung, H., Topp, M. S., Houot, R., Beitinjaneh, A. & Peng, W. & 5 others, , Apr 2 2020, In: New England Journal of Medicine. 382, 14, p. 1331-1342 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1385 Scopus citations -
Utility of high-throughput sequencing of T-cell receptor rearrangements in assessing treatment response in patients with mature T-cell lymphoma
Phull, P. M., Tan, C. R., Fung, H. C., Fields, P. A., Liu, Y., Zain, J., Fowler, N. H., Alpaugh, R. K., Oki, Y. & Barta, S. K., Dec 2020, In: Precision Cancer Medicine. 3, December, 31.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Chung, W., Kelly, A. D., Kropf, P., Fung, H., Jelinek, J., Su, X. Y., Roboz, G. J., Kantarjian, H. M., Azab, M. & Issa, J. P. J., Jul 22 2019, In: Clinical Epigenetics. 11, 1, p. 106 106.Research output: Contribution to journal › Article › peer-review
Open Access23 Scopus citations
Press/Media
-
Around Town
Testa, J. R., Bellacosa, A., Hall, M. J., Farma, J. M. & Fung, H. C.
03/5/25
1 item of Media coverage
Press/Media
-
Around Town
Testa, J. R., Bellacosa, A., Hall, M. J., Farma, J. M. & Fung, H. C.
03/2/25
1 item of Media coverage
Press/Media
-
Fox Chase Cancer Center Department of Bone Marrow Transplant and Cellular Therapy Awarded Reaccreditation
02/28/25
1 item of Media coverage
Press/Media
-
QOL a Crucial Consideration During R/R Myeloma Treatment Decision-Making
11/12/24
1 item of Media coverage
Press/Media
-
KRd56 Versus KRd27 Shows Similar Effectiveness, Safety in R/R Multiple Myeloma
11/7/24
1 item of Media coverage
Press/Media